GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Tien Liang Biotech Co 4127.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

34.45

+4.24%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 511.8m

FY2016FY2025

Net income

−TWD 10.3m

FY2016FY2025

Free cash flow

−TWD 4.1m

FY2016FY2025

Shareholders' equity

TWD 474.0m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 511.8mTWD 385.2mTWD 460.0mTWD 528.5mTWD 571.3mTWD 431.1mTWD 435.9mTWD 533.8mTWD 515.5mTWD 755.5m
Gross profitTWD 287.9mTWD 229.9mTWD 286.1mTWD 336.5mTWD 338.3mTWD 252.0mTWD 241.8mTWD 281.3mTWD 256.0mTWD 451.0m
Research and developmentTWD 4.6mTWD 2.5mTWD 1.3mTWD 1.4mTWD 1.2mTWD 1.2mTWD 991,000TWD 2.6mTWD 1.7mTWD 1.9m
Operating income−TWD 16.1mTWD 593,000TWD 20.4mTWD 61.1mTWD 50.6m−TWD 46.6m−TWD 43.4m−TWD 65.1m−TWD 195.5m−TWD 32.3m
Net income−TWD 10.3mTWD 11.7mTWD 17.7mTWD 59.5mTWD 46.6m−TWD 51.6m−TWD 46.8m−TWD 94.5m−TWD 203.5m−TWD 53.3m
Diluted earnings per share-0.220.250.391.301.00-1.10-1.00-2.07-4.45-1.17

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 1.18bnTWD 888.7mTWD 654.0mTWD 676.4mTWD 655.3mTWD 624.9m—TWD 740.6mTWD 924.1mTWD 1.39bn
Cash and short-term investments—TWD 130.7mTWD 142.2mTWD 107.8mTWD 118.5mTWD 115.2mTWD 55.7mTWD 171.0mTWD 229.6mTWD 160.4m
Total liabilitiesTWD 709.2mTWD 410.8mTWD 161.1mTWD 201.3mTWD 241.3mTWD 257.7m—TWD 274.6mTWD 367.8mTWD 629.3m
Debt—TWD 345.2mTWD 84.7mTWD 114.1mTWD 156.9mTWD 184.3mTWD 99.8mTWD 167.7mTWD 184.9mTWD 427.7m
Shareholders' equityTWD 474.0mTWD 477.9mTWD 493.0mTWD 475.1mTWD 414.1mTWD 367.3m—TWD 466.0mTWD 556.2mTWD 765.2m
Shares outstanding47m47m45m46m47m47m47m46m46m46m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 19.2mTWD 48.3mTWD 69.7mTWD 21.9mTWD 45.2m−TWD 10.8m—−TWD 3.5m−TWD 99.1m−TWD 33.6m
Capital spending−TWD 23.3m−TWD 4.1m−TWD 5.3m−TWD 1.0m−TWD 597,000−TWD 1.5m—−TWD 21.9m−TWD 15.5m−TWD 25.0m
Free cash flow−TWD 4.1mTWD 44.2mTWD 64.3mTWD 20.9mTWD 44.6m−TWD 12.3m—−TWD 25.4m−TWD 114.6m−TWD 58.6m
Dividends paid—−TWD 22.9m———————−TWD 13.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 184.7mTWD 198.3mTWD 131.7mTWD 136.2mTWD 127.3mTWD 116.6mTWD 86.9mTWD 97.0m
Gross profitTWD 111.9mTWD 118.4mTWD 74.3mTWD 74.7mTWD 69.9mTWD 69.1mTWD 49.1mTWD 59.7m
Operating incomeTWD 9.8mTWD 17.7m−TWD 24.6mTWD 2.7m−TWD 2.5mTWD 8.2m−TWD 5.2mTWD 2.3m
Net incomeTWD 14.2mTWD 34.2m−TWD 2.7mTWD 23.4m−TWD 48.6mTWD 17.6mTWD 4.3mTWD 3.3m
Diluted earnings per share0.300.73-0.060.50-1.040.380.090.07
Cash from operationsTWD 26.0mTWD 20.0m−TWD 13.0mTWD 12.0m−TWD 4.0mTWD 24.0mTWD 27.0mTWD 7.0m
Capital spending—−TWD 10.0m−TWD 7.0m−TWD 11.0m−TWD 3.0m−TWD 1.0m−TWD 1.0m−TWD 2.0m
Free cash flow—TWD 10.0m−TWD 20.0mTWD 1.0m−TWD 7.0mTWD 23.0mTWD 26.0mTWD 5.0m
Total assetsTWD 1.22bnTWD 1.22bnTWD 1.18bnTWD 1.22bnTWD 1.06bnTWD 1.06bnTWD 888.7mTWD 786.9m
Cash and short-term investments——————TWD 130.7mTWD 324.7m
Debt——————TWD 345.2mTWD 268.6m
Shareholders' equityTWD 519.3mTWD 503.3mTWD 474.0mTWD 478.3mTWD 450.4mTWD 498.1mTWD 477.9mTWD 476.6m

Financial ratios

Data as of 31 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin56.3%59.7%62.2%63.7%59.2%58.4%
Operating margin-0.1%4.2%4.5%11.6%8.9%-10.8%
Net margin-2.0%3.0%3.9%11.3%8.2%-12.0%
Return on equity-2.2%2.4%3.6%12.5%11.3%-14.1%
Return on assets-0.9%1.3%2.7%8.8%7.1%-8.3%
Free cash flow yield—3.2%4.8%1.4%——
Revenue growth32.9%-16.3%-13.0%-7.5%32.5%-1.1%
Earnings growth-187.6%-34.0%-70.2%27.6%-190.3%10.4%
Current ratio0.40x0.61x2.13x1.76x1.32x1.04x
Debt to equity—0.72x0.17x0.21x0.32x0.47x
Equity ratio40.1%53.8%75.4%70.2%63.2%58.8%
Interest coverage-0.06x5.25x9.85x34.48x27.34x-23.77x
R&D as a share of sales0.9%0.6%0.3%0.3%0.2%0.3%
Buybacks as a share of market value—-3.6%1.6%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-1.1%3.5%-4.8%
Operating income—-19.1%—
Net income—-27.6%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin57.7%60.5%59.9%58.6%
Operating margin-1.7%3.5%2.4%-3.2%
Net margin0.2%4.2%2.5%-4.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-141.3165.836.911.914.8-10.1-9.4-5.0-2.6-15.2
Price to sales2.85.01.41.31.21.21.00.91.01.1

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 27 Aug 2024.

FY2024
Paid in the year0.50
  • 104-for-100 split · 24 Sept 2008

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.